Theoretical-Experimental Analysis to Elucidate the Mechanism of Action of Novel Anabolic Agents
Molecules · 2025
DOI: 10.3390/molecules30224486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Israel Quiroga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Health Sciences, Universidad Popular Autónoma del Estado de Puebla, 13 Poniente No. 1927, Barrio de Santiago, Puebla 72410, Me…. Hauptthemen laut MEDLINE: Anabolic Agents, Hydrazones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia Tecnología e Innovación, CONAHCyT-SECIHTI.
Abstract (Originalsprache)
Research into muscle tissue pathologies offers great opportunities for new pharmaceutical agents. Current therapies, including corticosteroids and immunosuppressants, have limited efficacy and significant adverse effects. In this context, steroidal hydrazone compound 4d was investigated for its ability to promote muscle growth and regeneration as a potential anabolic and regenerative modulator. Flow cytometry analysis showed that 4d significantly increases cell populations in S phase, indicating a strong proliferative stimulus in pathways regulated by TNF-α, AKT, MAFbX, and SMAD2/3. Molecular docking studies showed that 4d shares strong interactions with the known MasR agonist (EP-2825), exhibiting a higher predicted binding affinity. Furthermore, 4d demonstrated the ability to interact with ACVR1/2A receptors, mimicking the binding profiles of known antagonists and potentially inhibiting myostatin/SMAD signaling. Taken together, experimental and computational evidence supports a dual-mechanistic model in which 4d promotes muscle proliferation and regeneration by (1) activating the MasR–PI3K/AKT/mTOR axis and (2) inhibiting the ACVR1/2A–SMAD pathway, counteracting the action of myostatin. These findings position compound 4d as a promising therapeutic candidate against muscle wasting disorders, including cancer-related cachexia, by inducing a robust and multifactorial anabolic response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life and Health Sciences, Universidad Popular Autónoma del Estado de Puebla, 13 Poniente No. 1927, Barrio de Santiago, Puebla 72410, Mexico.
- Laboratorio de Fisiología Celular, Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla 72420, Mexico.
- Laboratorio de Flujo Continuo y Fotoquímica, Centro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico.
- Laboratorio de Investigación, Herbario y Jardín Botánico Universitario, Benemérita Universidad Autónoma de Puebla, Puebla 72570, Mexico.
ORCID-Profile: Israel Quiroga, Maura Cardenas-Garcia, María Guadalupe Hernández-Linares, Gabriel Guerrero-Luna, Fermín Flores-Manuel
Förderung
- Secretaría de Ciencia Tecnología e Innovación
- CONAHCyT-SECIHTI
Zitieren
APA
Quiroga, I., Cardenas-Garcia, M., Hernández-Linares, M. G., Guerrero-Luna, G., & Flores-Manuel, F. (2025). Theoretical-Experimental Analysis to Elucidate the Mechanism of Action of Novel Anabolic Agents. Molecules. https://doi.org/10.3390/molecules30224486
Vancouver
Quiroga I, Cardenas-Garcia M, Hernández-Linares MG, Guerrero-Luna G, Flores-Manuel F. Theoretical-Experimental Analysis to Elucidate the Mechanism of Action of Novel Anabolic Agents. Molecules. 2025. doi:10.3390/molecules30224486
BibTeX
@article{Quiroga2025,
author = {Quiroga, Israel and Cardenas-Garcia, Maura and Hernández-Linares, María Guadalupe and Guerrero-Luna, Gabriel and Flores-Manuel, Fermín},
title = {Theoretical-Experimental Analysis to Elucidate the Mechanism of Action of Novel Anabolic Agents},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30224486}
}
EUVIMED